Therefore, it is speculated that anagliptin enhanced the anti-tumor effect of anti-PD-L1 by decreased generation of M2 macrophages and indirectly enhanced infiltration and activity of CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.